Greenleaf Peter (CIK 0001363683)

Latest company ownership

Shares held
443,973
Last filed at
Mar 4, 2025
Confidence Score
50.6
2025Q4
Confidence Score History
2021Q2 2025Q4
Shares held
272,988
Last filed at
Oct 3, 2019
Confidence Score
50.0
2025Q4
Confidence Score History
2018Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Feb 28, 2025 Mar 4, 2025 Aurinia Pharmaceuticals Inc. CEO Sell 100.0 +263,893 17.30% ✗ $2.9M
Mar 6, 2024 Mar 7, 2024 Aurinia Pharmaceuticals Inc. CEO Sell 40.0 -126,981 -7.70% ✗ $711.1K
Mar 2, 2023 Feb 22, 2024 Aurinia Pharmaceuticals Inc. CEO Sell 40.0 -33,047 -3.25% ✗ $290.2K
Mar 2, 2023 Mar 6, 2023 Aurinia Pharmaceuticals Inc. CEO Sell 97.5 +634,657 182.21% ✗ $292.8K
Mar 2, 2022 Mar 4, 2022 Aurinia Pharmaceuticals Inc. CEO Sell 95.0 +19,232 140.02% ✗ $108.9K
May 11, 2021 May 12, 2021 Aurinia Pharmaceuticals Inc. CEO Buy 95.0 +5,125 61.54% ✗ $54.9K
May 18, 2018 May 21, 2018 Avalo Therapeutics, Inc. CEO Buy 83.8 +12,500 3.13% ✗ $49.8K